This evidence suggests that BiP/GRP78 can play a neuroprotective role in the initial phase of AD, but with the progression of the disease its decreased levels can attenuate the UPR signaling pathway resulting in an accumulation of unfolded proteins, namely APP. Here, APP is linked to Alzheimer disease.